AMFI - Registered Mutual Fund Distributor

Curis Lifesciences Limited IPO

Curis Lifesciences Limited IPO

₹ 256000 / 2000 Shares Shares
Minimum Investment

Curis Lifesciences Limited IPO

Issues Price

₹120-128 per equity share

Curis Lifesciences Limited IPO

Open Date

07 Nov 2025

Close Date

11 Nov 2025

Lot Size

1000

Min. Investment

₹ 256000

Issue Price

₹120-128

Listing Date

14 Nov 2025

Issues Size

21,50,000 shares(aggregating up to ₹27.52 crore)

Face Value

₹10 Per Equity Share

Total Shares Offered

2000 Shares

Offered To Public

2000 Shares

Curis Lifesciences Limited IPO

Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.

Founded In

2020

Managing Director

Dharmesh Dasharathbhai Patel

Parent Organization

Curis Lifesciences Limited IPO

Application for Curis Lifesciences Limited IPO

Apply as Price Range Apply Upto
Individual (min) ₹120-128 ₹2,56,000
Individual(max) ₹120-128 ₹2,56,000
SHNI(min) ₹120-128 ₹3,84,000
SHNI(max) ₹120-128 ₹8,96,000
BHNI(min) ₹120-128 ₹10,24,000

Apply for all eligible candidates, Curis Lifesciences Limited IPO.

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹2061-2165

ksquare

Open On15 Dec 2025

Close On17 Dec 2025

Price Range₹126

ksquare

Open On12 Dec 2025

Close On16 Dec 2025

Price Range₹135-142

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹94-96

ksquare

Open On11 Dec 2025

Close On15 Dec 2025

Price Range₹112-118

ksquare

Open On10 Dec 2025

Close On12 Dec 2025

Price Range₹12


Testimonial

Genuine Review Form Statisifed Customers

4.5 Out of 5 (6634 Reviews)

Investing in India felt intimidating until I found KSquare. Their NRI Corner made it straightforward and transparent. It’s exactly what I needed living abroad.

Divya Bhatia

Divya Bhatia

University Lecturer

I always tell clients about KSquare now. Their SIP system is efficient and perfectly tailored to long-term growth strategies. It’s my go-to investment tool.

Aditya Rao

Aditya Rao

Chartered Accountant

Thanks to KSquare, my retirement plan feels organized. Their NPS tools and knowledge gave me real confidence in the future.

Tanya Khosla

Tanya Khosla

PR Consultant

I love how KSquare offers mutual fund plans that match my income flow and future goals. They’ve made saving and investing seamless for me.

Nirali Parekh

Nirali Parekh

Clinical Dietician

KSquare’s service was fast, transparent, and easy to follow. Perfect for someone like me who needed quick access to funds.

Pooja Khurana

Pooja Khurana

Pediatric Nurse

I never thought mutual fund investing could be this simple. KSquare helps me manage risk and meet financial targets effortlessly. Great for working women like me.

Neha Bajaj

Neha Bajaj

Human Resource Lead

KSquare offered me a quick solution when I needed funds. They made the loan process easy to understand and access.

Sneha Dugar

Sneha Dugar

Academic Counselor

With KSquare’s help, I finally understood the benefits of NPS. Their team is responsive and really knows their stuff.

Dinesh Rawal

Dinesh Rawal

Transport Manager

KSquare guided me in building a strong emergency fund. I now feel safe knowing unexpected medical or financial situations won’t disturb our family. Truly reliable and dedicated service.

Deepika Reddy

Deepika Reddy

KSquare’s pension guidance was much needed. Their team helped me select the right NPS tier and gave detailed explanations.

Poonam Seth

Poonam Seth

NGO Coordinator

FAQ's

Frequenlty Asked Question

What is the role of a fund manager in mutual funds?

Fund managers decide where to invest the pooled money, aiming to maximize returns based on the fund’s strategy.

Which types of mutual funds are eligible for loans?

Typically, equity and debt mutual fund units held in demat form are eligible. KSquare helps confirm your fund’s eligibility instantly.

How do I track my investments from overseas?

KSquare’s online dashboard lets NRIs monitor and manage portfolios 24/7, no matter where they are in the world.

Is NPS a market-linked investment?

Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.

Can I prepay the loan without penalties?

Most lenders allow prepayment without extra charges. KSquare ensures these terms are clearly shared before you proceed.

How do I manage taxes on my investments as an NRI?

KSquare provides tax guidance specific to NRIs, helping you plan and stay compliant with Indian tax laws.

What documents are needed for applying LAMF?

Basic KYC documents, bank statements, and demat account details are required. KSquare helps with digital submission.

Why should I choose KSquare for my SIP needs?

KSquare offers expert support, real-time tracking, flexible options, and a user-friendly platform to grow your wealth steadily.

App Store

Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.